Clinical Validation of a New Algorithm for Computerized Dosing of Vitamin K Antagonist Therapy
NCT ID: NCT01392040
Last Updated: 2013-01-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
100 participants
OBSERVATIONAL
2010-11-30
2013-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prospective Trial of a Validated Algorithm for Warfarin Dosing
NCT02705976
Effect of Vitamin K in Critically Ill Patients
NCT03782025
Anticoagulant Clinics and Vitamin K Antagonists
NCT00966290
Reinitiation of Anticoagulation After Temporary Withdrawal of Vitamin K Antagonist
NCT01348074
Efficacy of Direct Oral Anticoagulants as a Prophylactic Anticoagulation of Catheter Induced Thrombosis
NCT05705076
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients in oral anticoagulant therapy
Patients taking oral anticoagulant therapy
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* to be in stable conditions for at last 3 months
Exclusion Criteria
* patients who interrupt therapy
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Of Perugia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Alfonso Iorio
Dt
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michela Basileo, Dr
Role: PRINCIPAL_INVESTIGATOR
University Of Perugia
Alfonso Iorio, Dr
Role: PRINCIPAL_INVESTIGATOR
McMaster University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital of Macerata
Macerata, Macerata, Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MIV_AI_10_001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.